Category: Johnson & Johnson
-
STAT+: Bayer sues J&J over ‘false and misleading claims’ about competing prostate cancer treatments
STAT+: Bayer sues J&J over ‘false and misleading claims’ about competing prostate cancer treatments Underscoring the high-stakes market for prostate cancer medicines, Bayer filed a lawsuit accusing Johnson & Johnson of launching a “false advertising campaign” that uses flawed data to wrongfully promote its rival drug as a more effective treatment. At issue are claims…
-
STAT+: On Day 4 of JPM, a chat with Regeneron’s George Yancopoulos, an IPO forecast, and all eyes on J&J
STAT+: On Day 4 of JPM, a chat with Regeneron’s George Yancopoulos, an IPO forecast, and all eyes on J&J This is the online version of The Readout, STAT’s flagship biotech newsletter. Sign up to get it in your inbox. We have made it! And so have you. This is Adam, Elaine, Matt, and Allison preparing to sign…
-
Texas lawsuit against companies behind Tylenol asserts unproven claims of autism risk
Texas lawsuit against companies behind Tylenol asserts unproven claims of autism risk Texas Attorney General Ken Paxton on Tuesday accused the companies behind Tylenol of deceptively marketing the pain reliever to pregnant mothers in a lawsuit that asserted unproven claims that early exposure to acetaminophen increased risk of autism and other disorders. Paxton, an ally of President…